Vergoeding 2018-2022 voor ATC-subgroep M03BX : Overige centraal werkende middelen
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| M03BX01 Baclofen (Lioresal ®) | 1.831.300 | 1.893.800 | 1.954.900 | 2.064.900 | 2.161.900 |
| M03BX02 Tizanidine (Sirdalud ®) | 289.060 | 292.780 | 322.160 | 320.060 | 322.620 |
| M03BX04 Tolperison (Tolpermyo ®) | 231.890 | 276.590 | 329.540 | 379.680 | 437.420 |
| Totaal | 2.352.250 | 2.463.170 | 2.606.600 | 2.764.640 | 2.921.940 |